Vaccine Therapy Articles & Analysis
15 articles found
Applications Across Therapeutic Modalities l Monoclonal antibodies (mAbs): Platform downstream processes using Protein A capture and polishing chromatography are standard, though process intensification is ongoing. l Vaccines: Viral vaccines often require ultracentrifugation, chromatography, and filtration steps adapted to large viral particles. l Gene ...
Adenoviruses are a group of viruses that have gained significant attention in recent years, particularly in the fields of gene therapy, vaccine development, and cancer treatment. With their ability to deliver genetic material into cells effectively, adenoviruses serve as valuable vectors in various biomedical applications. ...
The COVID-19 pandemic has illuminated the critical need for innovative strategies in antiviral research, and scientists worldwide are embarking on groundbreaking projects to develop more effective therapies, vaccines, and preventive measures against a myriad of viral pathogens The Rise of Next-Generation Antivirals One of the most promising frontiers in ...
In recent years, messenger RNA (mRNA) technology has emerged as a revolutionary approach in the field of medicine, particularly in vaccine development and gene therapy. The ability to deliver mRNA effectively to target cells is crucial for harnessing its potential in treating a variety of diseases, including infectious diseases, cancer, and genetic disorders. ...
Custom mRNA production has emerged as a cutting-edge technology in the field of molecular biology, offering researchers the ability to tailor-make specific messenger RNA molecules for various applications such as vaccine development, gene therapy, and regenerative medicine. This innovative process holds great promise in unlocking new possibilities in scientific ...
The stability in vivo and effective protein synthesis in vitro are essential for ensuring the efficacy of mRNA-based vaccines and therapies. In vitro transcribed (IVT) mRNA needs to be capped at the 5' end through post-transcriptional enzyme capping or co-transcriptional capping. ...
With their utilization, researchers can track the body's immune response to infections, cancer, or vaccines, enhancing our understanding of immune responses and paving a way for improved vaccines and therapies. ...
Introduction RNA Lipid Nanoparticles (LNP) technology has rapidly gained prominence in the health and scientific domain, primarily due to its significant role in carrying the mRNA of the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. Yet, the potential of this technology spans beyond the confines of these vaccines or even the health industry. ...
Liposomes are also being investigated for delivery of gene therapies, vaccines, and diagnostic agents. Conclusion Drug-loaded liposomes represent a significant advancement in drug delivery technology. ...
This article highlights the current heated pseudoUridine modification in RNA, which suggests new possibilities for novel drug or vaccine discovery. An Introduction to PseudoUridines PseudoUridine (Ψ) is a post-transcriptional RNA modification that alters RNA-RNA and RNA-protein interactions and affects gene expression. ...
Background Tumor immunotherapies compose immune checkpoint inhibitors, therapeutic antibodies, tumor vaccines, cellular therapies, and so on. However, each has its own set of issues, such as the fact that CAR-T therapy is an individual therapy that is costly; immune checkpoint inhibitors are highly effective, but only in some ...
People infected with either of these diseases have a 50% to 100% chance of dying. There is already a vaccine approved for use on horses and a modified vaccine has entered human clinical trials. ...
A breakthrough in nanotechnology accelerates vaccine production While COVID-19 hotspots have continued to emerge driven by the Delta variants, the data still shows that vaccinations are effective at preventing hospitalizations and deaths. While over 4 billion vaccine doses have been administered worldwide, only 27% of the world’s population and only 1.1% of people in low-income countries ...
There is no cure and no approved vaccine for herpes or immunomodulating therapies for the disease. For Fernandez, who has HSV-1, herpes is personal. ...
If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? No, in fact vaccines have been shown to be highly effective at preventing hospitalizations and deaths from these SARS-CoV-2 variants. While the infamous Delta variant has now been detected in 98 countries and all 50 states, 99% of all COVID-19 deaths and hospitalization cases are unvaccinated, according to ...